These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2007-003126-15||Randomized trial of sequential epirubicin and docetaxel against docetaxel in patients with early operable breast cancer.||bad-data|
|Not reported Terminated||2008-005067-33||Randomized trial of endocrine therapy against locoregional therapy first. A DBCG trial in postmenopausal patients with operable hormone receptor positive tumors larger than 1 cm.||2012-12-31||due-trials|
|Completed, but no date, and reported results Terminated||2012-002347-23||Phase II study of irinotecan weekly in combination with trastuzumab in patients with locally advanced or metastatic HER2-positive breast cancer and increased cancer cell copy number of TOP1”||bad-data|
|Completed, but no date, and reported results Terminated||2012-002348-26||Phase II study of irinotecan weekly in patients with locally advanced or metastatic HER2-negative breast cancer and increased cancer cell copy number of the topoisomerase 1 gene (TOP1)”||bad-data|